Show simple item record

dc.contributor.authorElmarjany, Mohammed
dc.contributor.authorMaghous, Abdelhak
dc.contributor.authorRazine, Rachid
dc.contributor.authorMarnouche, Elamin
dc.contributor.authorAndaloussi, Khalid
dc.contributor.authorBazine, Amine
dc.contributor.authorLalya, Issam
dc.contributor.authorZaghba, Noha
dc.contributor.authorHadadi, Khalid
dc.contributor.authorSifat, Hassan
dc.contributor.authorHabib, Baba
dc.contributor.authorKouach, Jaouad
dc.contributor.authorMansouri, Hamid
dc.date.accessioned2015-09-01T17:28:21Z
dc.date.available2015-09-01T17:28:21Z
dc.date.issued2015-12-21
dc.identifier.citationGynecologic Oncology Research and Practice. 2015 Dec 21;2(1):2
dc.identifier.urihttp://dx.doi.org/10.1186/s40661-015-0009-y
dc.identifier.urihttp://hdl.handle.net/10724/31797
dc.description.abstractAbstract Background Cancer of uterine cervix is the second most common cause of cancer related deaths among women. The aim of this study is to report the experience of Military Hospital Mohamed V in the management of cervical cancer and their results. Methods All cervical cancer managed at the radiotherapy department of Military Hospital Mohamed V between January 2005 and February 2010, were included for investigation of their demographic, histological, therapeutic and follow-up characteristics. Of the 162 cases managed, 151 (93.2 %) cases were treated in our department. Results In our study the median age was 51.5 years (33–82). The median duration of symptoms before diagnosis was four [3, 7] months. The major presenting complaints were abnormal vaginal bleeding (89.8 %). Squamous cell carcinoma cervix was seen in 86.2 % (n = 137), adenocarcinoma in 11.3 % (n = 18) and adenosquamous carcinoma in 2.4 % (n = 4). One hundred seventeen (84.8 %) cases were seen at late stage. An abdominal and pelvic computed tomography (CT) scan was performed in 34.6 % (n = 56) of cases, magnetic resonance imaging (MRI) in 62.9 % (n = 102). The pelvic lymph nodes were achieved in 16.6 % of cases. Over half of patients 58.3 % (n = 88) were treated with a combination of external beam radiation therapy (EBRT) and a concurrent cisplatin based chemotherapy (40 mg /m2 weekly). With a mean of 51.6 months (2 to 109), we recorded 19 (12.6 %) pelvic relapse and 15 (9.9 %) metastases. The median time to onset was 19.4 months (2–84 months). The local control rate was 63.6 % (n = 96) and 21 (13.9 %) patients were lost to follow-up. The overall survival (OS) at 3 years and 5 years was respectively 78.3 % and 73.6 % and the relapse-free survival (RFS) was respectively 80 % and 77.2 %. Conclusion Most of cervical cancer patients in Morocco are seen at late stage necessitating referral for radiotherapy, chemotherapy or palliative care. This may reflect lack of cervical screening in order to early detect and treat pre-malignant disease stage.
dc.titleDiagnostic, therapeutic and evolutionary characteristics of cervical cancer in Department of Radiotherapy, Mohamed V Military Hospital – Rabat in Morocco
dc.typeJournal Article
dc.date.updated2015-07-29T18:30:39Z
dc.language.rfc3066en
dc.rights.holderElmarjany et al.; licensee BioMed Central.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record